{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:14:59Z","timestamp":1789676099931,"version":"4.0.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To determine whether prepregnancy insulin resistance and its improvement during ovulation induction are associated with fertility and pregnancy outcomes in women with polycystic ovarian syndrome (PCOS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This secondary analysis used data from PPCOS II (Pregnancy in Polycystic Ovary Syndrome II), a multicenter randomized trial. This analysis included women aged 18\u201340 years with PCOS who were undergoing ovulation induction with clomiphene citrate or letrozole. Insulin resistance was assessed at screening and at end-of-treatment visits by using the homeostatic model assessment of insulin resistance (HOMA-IR), the quantitative insulin sensitivity check index, and the glucose-to-insulin ratio. The primary outcome was clinical pregnancy, and secondary outcomes included gestational diabetes mellitus (GDM), preeclampsia, and preterm delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Among 746 women, higher prepregnancy HOMA-IR quartiles were associated with decreased ovulation (93.5% vs 87.8% vs 75.4% vs 73.8%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for trend &lt;.001), lower clinical pregnancy (36% vs 25.5% vs 23.52% vs 26.5%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.005,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for trend=.001) and live-birth rates (35.5% vs 19.7% vs 20.3% vs 18.2%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for trend &lt;.001), and higher risk of GDM (13.8% vs 15.4% vs 22.5% vs 45.7%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.002,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for trend &lt;.001). Women in the highest HOMA-IR quartiles experienced delayed first ovulation and more frequent obstetric complications, especially increased risks of GDM. Improvement in the HOMA-IR during treatment was associated with increased odds of clinical pregnancy and reduced risk of preeclampsia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Prepregnancy insulin resistance is associated with impaired fertility and increased pregnancy complications in women with PCOS. Assessment and improvement of insulin resistance before fertilization may enhance reproductive success and reduce obstetric risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT00719186.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006318","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:02:08Z","timestamp":1779397328000},"page":"556-563","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prepregnancy Insulin Resistance and Fertility and Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome"],"prefix":"10.1097","volume":"148","author":[{"given":"Bo Hyon","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Kyo","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline Yano","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazim","family":"Dowlut-McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Gomez-Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"R1-20260917","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/REP-10-0088","article-title":"Obesity, insulin resistance, and pregnancy outcome","volume":"140","author":"Catalano","year":"2010","journal-title":"Reproduction"},{"key":"R2-20260917","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/1471-0528.13339","article-title":"Pregnancy and perinatal outcomes in women with polycystic ovary syndrome and twin births: a population-based cohort study","volume":"122","author":"Lovvik","year":"2015","journal-title":"BJOG"},{"key":"R3-20260917","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R4-20260917","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/cen.13860","article-title":"Prevalence and degree of insulin resistance in Chinese Han women with PCOS: results from euglycemic-hyperinsulinemic clamps","volume":"90","author":"Li","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R5-20260917","doi-asserted-by":"crossref","first-page":"e0292623","DOI":"10.1371\/journal.pone.0292623","article-title":"Lean mass and associated factors in women with PCOS with different phenotypes","volume":"18","author":"Fighera","year":"2023","journal-title":"PLoS One"},{"key":"R6-20260917","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejogrb.2022.01.025","article-title":"Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review","volume":"271","author":"Magzoub","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R7-20260917","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"R8-20260917","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5114\/aoms.2019.82672","article-title":"How much insulin resistance in polycystic ovary syndrome? Comparison of homeostasis model assessment of insulin resistance and insulin resistance (Belfiore) index models","volume":"15","author":"Lewandowski","year":"2019","journal-title":"Arch Med Sci"},{"key":"R9-20260917","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1600-0412.2012.01385.x","article-title":"Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview","volume":"91","author":"Ghazeeri","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R10-20260917","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40842-023-00156-3","article-title":"Assessment HOMA as a predictor for new onset diabetes mellitus and diabetic complications in non-diabetic adults: a KoGES prospective cohort study","volume":"9","author":"Lee","year":"2023","journal-title":"Clin Diabetes Endocrinol"},{"key":"R11-20260917","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2016-1726","article-title":"Association between insulin resistance and bone structure in nondiabetic postmenopausal women","volume":"101","author":"Shanbhogue","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20260917","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1414827","article-title":"Letrozole, gonadotropin, or clomiphene for unexplained infertility","volume":"373","author":"Diamond","year":"2015","journal-title":"N Engl J Med"},{"key":"R13-20260917","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.fertnstert.2019.12.023","article-title":"Pregnancy registry: three-year follow-up of children conceived from letrozole, clomiphene, or gonadotropins","volume":"113","author":"Legro","year":"2020","journal-title":"Fertil Steril"},{"key":"R14-20260917","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R15-20260917","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1210\/clinem\/dgab645","article-title":"Insulin resistance and cardiometabolic risk profile among nondiabetic American young adults: insights from NHANES","volume":"107","author":"Parcha","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-20260917","doi-asserted-by":"crossref","first-page":"e106641","DOI":"10.1371\/journal.pone.0106641","article-title":"Profile of individuals who are metabolically healthy obese using different definition criteria. A population-based analysis in the Spanish population","volume":"9","author":"Martinez-Larrad","year":"2014","journal-title":"PLoS One"},{"key":"R17-20260917","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/humrep\/deh580","article-title":"Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome","volume":"20","author":"S\u00f6nmez","year":"2005","journal-title":"Hum Reprod"},{"key":"R18-20260917","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/09513590.2011.614207","article-title":"A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight\/obese women with polycystic ovary syndrome","volume":"28","author":"Mohsen","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"R19-20260917","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2011-3061","article-title":"Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial","volume":"97","author":"Morin-Papunen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20260917","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"issue":"suppl 8A","key":"R21-20260917","doi-asserted-by":"crossref","first-page":"99S","DOI":"10.1016\/j.amjmed.2003.09.016","article-title":"Endothelial function, inflammation, and prognosis in cardiovascular disease","volume":"115","author":"Gonzalez","year":"2003","journal-title":"Am J Med"},{"key":"R22-20260917","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.CIR.104.3.342","article-title":"Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase","volume":"104","author":"Duplain","year":"2001","journal-title":"Circulation"},{"key":"R23-20260917","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCOUTCOMES.114.001563","article-title":"Insulin resistance and risk of cardiovascular disease in postmenopausal women: a cohort study from the women's health initiative","volume":"8","author":"Schmiegelow","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:00:27Z","timestamp":1789675227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006318","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"2026-01-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}